Introduction
As companies close out 2025 and look ahead to 2026, the pharmaceutical and life sciences sector is reporting strong commercial performance, forward-looking revenue guidance, and evolving market trends. Recent updates from Pharma Vanguard highlight how commercial execution, strategic forecasting,...
